Ingrid Skop, M.D., FACOG

CLI Vice President and Director of Medical Affairs Ingrid Skop, M.D., gave a testimony before the South Dakota Senate State Affairs Committee on March 2. The Senate State Affairs Committee considered House Bill amendment 1257D, clarifying the definition of what is not considered an abortion (i.e., treatment of ectopic pregnancy or miscarriage).

Mail-order abortion drugs have transferred the burden of monitoring pain, bleeding, and potential infection from experienced physicians to the women themselves. For the abortion industry, “access” now trumps standard medical care, and women have become collateral damage.

On January 23, CLI Vice President and Director of Medical Affairs Ingrid Skop, M.D., sat down with the Christian Broadcasting Network (CBN) at the 2026 March for Life to discuss the risks of abortion and what the pro-life movement should focus on.

Every state with strong pro-life laws allows doctors to intervene to save a woman’s life in a medical emergency.

This fact sheet lays out basic definitions and data related to maternal mortality, with a focus on false narratives surrounding the relationship between maternal mortality and abortion.

“Abortion up to birth” is sometimes used to describe abortions in the seventh, eighth, or ninth month of pregnancy. Although media coverage tends to focus on late-term abortions performed because the unborn baby has a serious health condition or the mother’s life is threatened, research indicates that many late-term abortions occur for reasons unrelated to serious maternal or fetal health concerns. And despite claims that born-alive abortion survivors are a myth, babies have survived late abortions.

CLI Vice President and Director of Medical Affairs Dr. Ingrid Skop discusses the dangers of abortion drugs, the lack of U.S. abortion data, and some of the abortion drug complications she has seen with patients.

CLI Vice President and Director of Medical Affairs Dr. Ingrid Skop discusses the risks of telehealth abortions.

CLI Vice President and Director of Medical Affairs Dr. Ingrid Skop explains how serious abortion drug complications can be.

Abortion data collection in the U.S. is seriously lacking. Currently, it’s impossible to study the real impact of abortion because of the many gaps in data.